2022
DOI: 10.1128/spectrum.02097-22
|View full text |Cite
|
Sign up to set email alerts
|

Emergence and Transmission of Plasmid-Mediated Mobile Colistin Resistance Gene mcr-10 in Humans and Companion Animals

Abstract: Colistin was considered as the last-resort drug against severe clinical infections caused by multidrug-resistant Gram-negative pathogens. Mobile colistin resistance ( mcr ) genes and its variants carried by plasmids have been reported in diverse niches in recent years, and yet few studies reported carriage of mcr-10 in ECC strains of companion animal origin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 39 publications
0
7
0
1
Order By: Relevance
“…The mobile colistin resistance genes, mcr , mediated by plasmids is the mechanism of concern leading to the wide dissemination of colistin resistance bacteria worldwide [ 45 ]. The mcr -carrying plasmids are characterized by the Inc-type, and the main Inc-type is different depending on the site of isolation.…”
Section: Discussionmentioning
confidence: 99%
“…The mobile colistin resistance genes, mcr , mediated by plasmids is the mechanism of concern leading to the wide dissemination of colistin resistance bacteria worldwide [ 45 ]. The mcr -carrying plasmids are characterized by the Inc-type, and the main Inc-type is different depending on the site of isolation.…”
Section: Discussionmentioning
confidence: 99%
“…This trend has facilitated unprecedented interactions and contact between wildlife, domestic animals, and humans, leading to potential ramifications [7] . Nevertheless, the AMR is poorly reported worldwide in this niche [8][9][10] .…”
Section: Introductionmentioning
confidence: 99%
“…This includes in animals where there has been appreciable use of colistin as a growth promoter in recent years [30], with studies now showing that 96% or more of total worldwide use of colistin is still in poultry and pig farming [31,32]. Concerns with the overuse of colistin including both animals and humans, and resultant resistance development via zoonotic gene transfers, coupled with its importance in treating resistant gramnegative infections to reduce morbidity and mortality, has resulted in the World Health Organization and others classifying colistin as an antibiotic of very high importance for use in humans with its use reserved [21,[33][34][35][36][37][38][39]. Alongside this, many countries now ban the use of colistin as a growth promoter in animal feeds and prophylactically to prevent bacterial infections [40][41][42].…”
Section: Introductionmentioning
confidence: 99%